The present study confirms these results and shows that PGR may be a useful natural tool, in combination with metformin, to achieve an additional reduction in BMI, glucose-insulin and adiposity parameters, reducing the number of patients with MetS to a significantly greater extent than metformin alone. This evidence concerns the gene INS and metabolic syndrome.